Erythropoietin for patients undergoing radiotherapy: a pilot study.

BACKGROUND AND PURPOSE To evaluate the feasibility and efficacy of using recombinant human erythropoietin (rhEPO) to correct decreased hemoglobin levels in patients undergoing radiotherapy and to get an estimate of its influence on the efficacy of radiotherapy. MATERIALS AND METHODS Fifty patients with cancer of the head and neck and the pelvis were… (More)